|
C7ORF44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.95290000000781E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.522000E-03 |
| Normal-vs-Stage2 |
9.087400E-01 |
| Normal-vs-Stage3 |
1.51879999998883E-06 |
| Normal-vs-Stage4 |
2.14159999999408E-05 |
| Stage1-vs-Stage2 |
1.218170E-01 |
| Stage1-vs-Stage3 |
1.186320E-02 |
| Stage1-vs-Stage4 |
2.762400E-02 |
| Stage2-vs-Stage3 |
6.520700E-03 |
| Stage2-vs-Stage4 |
6.139800E-03 |
| Stage3-vs-Stage4 |
8.149400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.53450000000199E-05 |
| Normal-vs-AfricanAmerican |
1.383330E-04 |
| Normal-vs-Asian |
3.683800E-03 |
| Caucasian-vs-AfricanAmerican |
3.202800E-01 |
| Caucasian-vs-Asian |
6.927200E-01 |
| AfricanAmerican-vs-Asian |
1.666950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.247280E-04 |
| Normal-vs-Female |
3.043300E-04 |
| Male-vs-Female |
4.585800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.464820E-03 |
| Normal-vs-Age(41-60Yrs) |
2.210300E-04 |
| Normal-vs-Age(61-80Yrs) |
7.424500E-03 |
| Normal-vs-Age(81-100Yrs) |
4.972300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.405400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.161200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.521000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.126200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.190800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.653600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.52060000000143E-05 |
| Classical-VS-Follicular |
4.26119999999974E-05 |
| Classical-VS-Other |
2.100200E-01 |
| Classical-VS-Normal |
3.11659999996383E-06 |
| Tall-VS-Follicular |
8.82420025938302E-10 |
| Tall-VS-Other |
8.132800E-01 |
| Tall-VS-Normal |
1.71309966212618E-10 |
| Follicular-VS-Other |
5.233500E-04 |
| Follicular-VS-Normal |
4.492800E-01 |
| Other-VS-Normal |
3.040900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.758240E-02 |
| Normal-vs-N1 |
6.031400E-04 |
| N0-vs-N1 |
8.850500E-02 |
|
|
